l Case material and methods
The analysis concerns 364 pregnant women whose pregnancies were terminated by delivery and who had been hospitalized at the Clinic of Endocrinology of the Institute of Gynecology and Obstetrics of the Medical Academy in Cracow in the years [1971] [1972] [1973] . CAP was determined by TUPPY'S method modified by KLIMEK [19] at pH = 7.9 (P-CAP) and pH = 6.0 (T.CAP) and AP and HSAP by KING and KING'S method modified by HANSEN [14] . In these women, prior to the present pregnancy, ovarian disorders and/or sterility had been diagnosed äs the cause of failure to become pregnant, and the majority (189 women) had been treated with hormones. Some of the women had been treated also during the present pregnancy because of diabetes (9 women), cervical incompetence (10 women), gestosis (7 women), threatened abortion (59 women), fetomaternal immunization (3 women), or toxoplasmosis (25 women activity is valuable in forecasting the birth of an Besides being evaluated according to normal or impaired or dead neonate, but not in predicting a abnormal enzyme activity, the women were low APGAR score. Half of the women with low divided according to whether they gave birth to activity of the enzyme will give birth to impaired healthy or impaired neonates. An analysis was children, but a välue above percentile 2.5 does made of all impaired or dead neonates (perinatal not exclude a threat to the infant because the mortality, congenital anomalies, one minute sensitivity of this test is low (about 85 per cent APGAR score below six, prematurity, intrauterine of impaired neonates are not detected). A falling \growth retardation, respiratory distress syndrome, P-CAP curve also indjcates general impairment of postmature fetuses, and neonates with hemolytic the neonate, but is not a prognostic sign of perinatal disease), and separately against the rest of the mortality or of a low APGAR score. Comparison material, perinatal mortality and low APGAR score with the single values shows that specificity of were analyzed. Statistical analysis was made using serial assays is somewhat löWer. Only a third of the 2 test applying YATES correction, at one women with abnormal profile of enzyme activity degree of freedom. In addition, sensitivity and gives birth to impaired children. On the otherhand, specificity of the enzyme assays were evaluated. the sensitivity of this test is higher, nearly 40 per Sensitivity was definedasthe percentage of women cent of mothers of future impaired infants show with abnormal enzyme assays among those who decreasing enzyme activity in the blood. Low gave birth to impaired neonates. Specificity was T-CAP activity of the serum (Tab. ) also proved Tab. I. Prognostic significance of the assays of serum placental oxytocinase activity. No.: number of women delivered of impaired newborns a: number öf women delivered of impaired or dead babies with of normal enzyme values (false negative test) b: number of women delivered of impaired or dead babies whose enzyme assays were abnormal (correct test) c: number of women delivered of normal babies whose enzyme assays were normal (correct test) d: number of women delivered of normal newborns with abnormal enzyme assay (false positive test) 2 : Chi-square test applying Yates correction : P: probability for one degree of freedom ' N.S.:not significant Specificity = g-^j X 100 Sensitivity = -~-X 100. to be prognostic of birth of an impaired infant. Sensitivity of this test is similar to that of P-CAP. The differences in perinatal mortality and low APGAR score in this group are not significant. Falling T-CAP activity was related only to low APGAR score and allows no conclusions concerning impairment of the neonate in general or perinatal mortality. Only one of every four women with falling T-CAP activity gives birth to impaired infants. 42 per cent of the mothers of impaired infants, and 86 per cent of women who gave birth to infants with a low APGAR score, had an abnormal T-CAP profile during pregnancy.
Tabs. III and IV show that neither single nor serial assays of AP and HSAP have value in predicting neonatal impairment. Sensitivity to test was higher for serial assays, and specificity for single ones, similarly to CAP, but lower äs a rule than those for both P-CAP and T-CAP.
Comments
Until now, evaluation of the enzyme activities under consideration varied. The opinion prevailed that the phosphatases have no prognostic value for predicting the state of the neonate [10, 12, 25, 29, 31] . Only a few authors emphasize that under pathologic conditions, mainly in gestoses and essential hypertension, a sudden rise or fall in HSAP concentration may be prognostically unfavorable [2, 13, 26] , and is an indication for strict monitoring rather than for therapeutic decisions [3] . CAPis considered by most authors to be useful in the diagnosis of threatened pregnancy [l, 4, 5, 7, 8, 16, 18, 20, 21, 22, 28] , although a few investigators hold the opposite opinion [9] . A special application of this enzyme assay is in the diagnosis of the hypothalamic post-pregnancy syndrome in pregnant women [23] , and the combination of CAP with AP and cytohormonal vaginal smears may be of value in the diagnosis of primary and secondary placental insufficiency [30] . Thepurpose 'cif this study was to compare the prognostic and diagnostic significance of the aforementioned enzyme assays in pregnant women at neuroendocrinological risk. We have not encountered an analysis of this type in the literature and that is why we did not subdivide our material into particular kinds of high-risk pregnancy which only accompanied the neuroendocrinological risk. It was previously found on our material that the arithmetic means of enzyme assays in different months of pregnancy were inversely proportional to the degree of risk to pregnancy [30] , but this was not sufficient äs a prognostic measure of the magnitude of risk in the event of an abnormal assay result. In view of the above, two criteria of abnormality have been proposed: low values and abnormal profile. Abnormally high values, postulated by some authors for CAP [27, 32] and AP [2, 13, 26], were not taken into account because in our material of pregnancy at neuroendocrinological risk, increased fetal jeopardy was accompanied by decreasing enzyme activities [30] . The results of the present analysis demonstrated prognostic value of oxytocinase assays in endocrinologically risky pregnancy. Assays of P-CAP and T-CAP were of almost equal significance, notwithstanding reports of a greäter usefulness of P-CAP [6] . On the other hand, this study confirms that phosphatase assays are of no value prognostically in neuroendocrinologically pathologic pregnancy. HSAP was riot superior to AP, äs some authors have claimed. In profile studies basedupon arithmetic means, AP was even more useful than HSAP [30] , probably owing to the greäter dispersion of the values of the latter. We also found that assays of CAP are helpful in the prögriosis of perinatal mortality and low APGAR score, i.e. conditions that are frequently encountered in "neuroendocrinological gestosis" [24] , the term denoting all neuroendocrinologic disturbance developed during pregnancy, including placental insufficiency, corpus luteum of pregnancy insufficiency etc. However, about a half of futüre mothers of impaired neonates have values outside the ränge of these assays. This is understandable in view of the fact that these enzyme activities reflect placental activity but are not directly related to fetal metabolism. In contemporary obstetric diagnostics, they should be supplemented by hormonal assays, especially estriol, examination pf amniotic fluid, ultrasonic examinations and others. If this is carried out, unpleasant unexpected situations in the delivery ward and neonatplotgical clinic will be avoided.
x>

Summary
Serum enzyme determinations are now well-established diagnostic tools in so-called "placental insufficiency". A good predictability of oxytocinases (P-CAP-placental oxytocinase and T-CAP-tissue oxytocinase) and a doubtful one of those of phosphatases (AP-alkaline phosphatase, HSAP-heat stable alkaline pho'sphatase) has been shown in high-risk pregnancies. The purpose of this study was to determine the prognostic value of the above cited enzymes in the so-called "pregnaricy at neuroendocrinological risk", i.e. pregnancy in women with a prepregnancy history of hormonal disorders. It was shown that the outcome and results of such pregnancies are poorer that those of normal pregnancies.
The series studied comprised 364 pregnant patients with pregnancy at neuroendocrinological risk that were being monitored by means of serum assays of the four enzymes. An attempt was made to assess each of these enzyme activities both in single (at least one value below 2.5 percentile calculated for healthy subjects) and serial determinations (two consecutive results decreasing or remaining at the same level). Normal and abnormal enzyme results were compared with normal and abnormal conditions of the newborn. The resuits presented showed that P-CAP (Tab. I) and T-CAP (Tab. II) levels were useful in prenatal diagnosis of fetal impaiiment in general, in addition to perinatal mortality and low values of the APGAR score. Neither the single nor serial assays of AP (Tab. III) and HSAP (Tab. IV) were valuable in predicting birth of an impaired neonate. Sensitivity of the test, i.e. percentage of women with abnormal enzyme assays among those patients who gave birth to impaired neonates, and specificity of the test, i.e. the percentage of women delivered of impaired neonates among all women with abnormal enzyme assays, of the four enzymes were compared. Sensitivity and specificity of P-CAP and T-CAP were higher than those for AP and HSAP. Moreover, sensitivity for all four enzymes was higher in serial assays, and specificity was higher in single assays. The results of the present analysis demonstrated the prognostic value of oxytocinase assays also in the pregnancy at neuroendocrinological risk. Assays of P-CAP and T-CAP were of equal significance, notwithstanding reports of a greater usefulness of P-CAP. Assays of CAP were helpful particularly in the conditions on which neuroendocrinological gestosis exerts a direct influence, i.e. in low Apgar score and perinatal mortality. On the other hand, serum alkaline phosphatases proved useless in endocrine pathology of pregnancy and HSAP was not superior to AP. About one half of future mothers of impaired neonates had enzyme results outside the ränge of the assays under consideration. This could be explained by the fact that these enzymes activities reflect placental function and are not directly related to fetal metabolism. Because of that they should be supplemented by other diagnostic methods being used in a clinic of high-risk pregnancy.
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